Colorectal Cancer

>

Latest News

Although the overall incidence of colorectal adenocarcinoma is decreasing, the reduction is primarily associated with patients 55 years and older.
Pancreatic/Colorectal Adenocarcinoma Rates Have Increased in Young Adults

April 15th 2025

Although the overall incidence of colorectal adenocarcinoma is decreasing, the reduction is primarily associated with patients 55 years or older.

Neoantigen-Specific TIL/Pembrolizumab Elicits Responses in GI Cancers
Neoantigen-Specific TIL/Pembrolizumab Elicits Responses in GI Cancers

April 8th 2025

FDA Approves Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC
FDA Approves Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC

April 8th 2025

HIPEC Does Not Add Benefit to Cytoreduction Surgery in CRC Peritoneal Metastasis
HIPEC Does Not Add Benefit to Cytoreduction Surgery in CRC Peritoneal Metastasis

March 31st 2025

Laparoscopic, histologic, and biomarker responses occurred at all dose levels of mitomycin treatment in patients with peritoneal metastases.
PIPAC-MMC Plus FOLFIRI Shows Feasibility, Safety in Peritoneal Metastases

March 31st 2025

Latest CME Events & Activities

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

View More

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

View More

<1
...
3738394041